A device to improve needle insertion for hemodialysis
Self-sealing needle guide system for reliable hemodialysis
This study is testing a new device that helps make needle insertions safer and more accurate for people getting hemodialysis, so they can have a better experience and reduce the risk of complications.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Flowpoint Medical INC NIH-funded |
| Lab location | 1 site (Overland Park, United States) |
| Project ID | NIH-11013179 on NIH RePORTER |
What this research studies
This research focuses on developing an innovative implantable device designed to enhance the safety and reliability of needle insertion for patients undergoing hemodialysis. The device features a 3D-printed titanium shell that accurately guides the hemodialysis needle to the correct insertion point, while a specialized valve minimizes bleeding upon needle removal. By utilizing advanced materials and engineering techniques, the research aims to refine the device's manufacturability and operational parameters, followed by testing its functionality in a large animal preclinical study. This approach seeks to address common complications associated with hemodialysis, such as infection and incorrect needle placement.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with end-stage kidney disease who require regular hemodialysis treatments.
Not a fit: Patients who are not undergoing hemodialysis or those with conditions that contraindicate the use of implantable devices may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the safety and efficiency of hemodialysis treatments for patients.
How similar studies have performed: Previous research has shown promise in using advanced materials and engineering techniques for improving medical devices, indicating potential success for this novel approach.
Where this research is happening
Overland Park, United States
- Flowpoint Medical INC — Overland Park, United States (Active)
Researchers
- Principal investigator: Bobe, Jason — Flowpoint Medical INC
- Study coordinator: Bobe, Jason
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.